Published on
October 22, 2024
- 20:30 GMT
Celmatix Nominates First Lead Compound in Oral Fertility Drug Program
NEW YORK, NY, UNITED STATES, October 22, 2024 /EINPresswire.com/ -- Celmatix Inc., the leading women’s health biotechnology company focused on ovarian biology, has announced the nomination of a lead compound in its oral Follicle Stimulating Hormone …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
